Effective combination therapy for telogen hair loss

Background. Telogen hair loss is one of the most common forms of alopecia, associated with a disruption in the phases of the hair growth cycle – specifically, the premature transition of the hair follicle into the telogen phase. The primary causes are the influence of triggering factors such as increased stress levels and previous illnesses. The main goal of therapy is to prolong the anagen phase and stimulate hair growth through the use of topical peptides and a multivitamin complex.

Objective. To study the effectiveness of a hair growth restoration method in the treatment of telogen alopecia using cosmetic hair growth products and dietary supplements.

Methods. The study involved 20 patients diagnosed with telogen alopecia who received treatment with the topical cosmetic products «Time to Grow» and the dietary supplement «Thick and Strong Hair» for 9 weeks. The effectiveness of the treatment was assessed at 3, 6, and 9 weeks after the start of therapy.

Results. The analysis of the study showed statistically significant changes in trichoscopy indicators in patients with telogen alopecia, demonstrating the effectiveness of using hair growth cosmetics (p<0.05). At the final assessment point, a reduction in hair loss was observed in 100 % of the subjects, along with improvements in hair quality and volume. A survey evaluating the participants’ subjective experiences demonstrated satisfaction with the treatment and adherence to the therapy.

Conclusion. The use of hair growth products and the dietary supplement «Time to Grow» has proven effectiveness in the treatment of telogen hair loss.

1. Shatokhina E. A., Kruglova L. S., Polonskaya A. S. Diffuse alopecia: trigger factors and treatment.– Pharmateka.– 2019; 8: 18–21. (In Russ.).

2. Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen Effluvium: A Review of the Literature. Cureus. 2020 May 27;12(5): e8320. doi: 10.7759/cureus.8320. PMID: 32607303; PMCID: PMC 7320655.

3. Kruglova L. S., Gismieva A. V. Diffuse telogen effluvium. Medical Bulletin of the Ministry of Internal Affairs.– 2020.-№ 5 (109).– P. 52.-56. (In Russ.).

4. Daunton A, Harries M, Sinclair R, Paus R, Tosti A, Messenger A. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review. Am J Clin Dermatol. 2023 Jul;24(4):513–520. doi: 10.1007/s40257-023-00760-0. Epub 2023 Apr 13. PMID: 37052778.

5. Yorulmaz A, Hayran Y, Ozdemir AK, Sen O, Genc I, Gur Aksoy G, Yalcin B. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. J Cosmet Dermatol. 2022 Jun;21(6):2610–2617. doi: 10.1111/jocd.14413. Epub 2021 Aug 27. PMID: 34449961.

6. Hughes EC, Syed HA, Saleh D. Telogen Effluvium. 2024 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 28613598.

7. Rebora A. Telogen effluvium: a comprehensive review. Clin Cosmet Investig Dermatol. 2019 Aug 21;12:583–590. doi: 10.2147/CCID.S 200471. PMID: 31686886; PMCID: PMC 6709511.

8. Kruglova L. S., Kotenko K. V., Korchazhkina N. B., Turbovskaya S. N. Physiotherapy methods in pediatric dermatology. Moscow, 2017. (In Russ.).

9. Potekaev N. N., Kruglova L. S. Laser in dermatology and cosmetology. (In Russ.). (3rd edition supplemented) 978-5-906099-91-4, 2018.

10. Sheptiy O. V., Kruglova L . S . , Korchazhkina N. B . , Kotenko K. V., Yamenskov V. V. Mechanisms of action of various lasers and differentiated indications for their use (Literature review). Bulletin of new medical technologies. Electronic publication. 2014. No. 1. P. 156. (In Russ.).